Topic: Sanofi-Aventis SA

A third of all British adults -- some 13 million people -- will be obese by 2012 if current trends continue, jeopardising their health and straining healthcare budgets, researchers said on Thursday. Almost half of them will be from low income and ...
Sanofi-Aventis ends research on troubled diet drug, 2 weeks after halting sales in EuropeFrench drugmaker Sanofi-Aventis is halting all research on a once-promising diet drug that never made it to the U.S. market.The Paris-based company, in the world's No. 4 drugmaker, said ...
Sanofi-Aventis suspends sales of anti-obesity drug Acomplia in EuropeFrench pharmaceutical company Sanofi-Aventis temporarily suspended sales of anti-obesity drug Acomplia in Europe, the company said Thursday, after health authorities said the drug's risks outweigh its benefits.Sanofi-Aventis will " immediately" start talks with non-EU ...
Sanofi-Aventis, one of many pharmaceutical behemoths under pressure from low-cost generics, took yet another blow Wednesday as news broke that its anti-obesity drug Acomplia has been linked to five deaths and 720 adverse drug reactions in Britain since its launch two years ...
We are living in an advanced world, which has changed its life style completely, and with change in life style many new complications have taken birth. Obesity is a disease, which has its lineage with modern life style. We are sustaining our ...
Good health is a blessing which is more valuable than millions of dollars. Once health starts deteriorating even a millionaire can become a beggar. Planned and proper life style ipso-facto keeps away from many diseases. Improper and unplanned life style is an ...